STAAR Surgical Company (NASDAQ: STAA) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $1.3B. The Maz Rating grades it against the other companies in its sector.
STAAR Surgical Company's current Maz Rating and its five factor grades are for members: log in to see them.
At $25.56, STAAR Surgical Company trades at 2542.4x trailing earnings, 3.9x sales and 3.4x book value, with an EV/EBITDA of 69.5. Over the last twelve months it generated about $330M of revenue and $504697 of net income. It runs a gross margin of 73.1%, an operating margin of 6.7% and a net margin of 0.2%. It shows return on equity of 0.1%, return on invested capital of 0.5% and a free cash flow yield of 1.4%. On the balance sheet: a debt-to-equity ratio of 0.09 and a current ratio of 4.68. Over the past 52 weeks the share price ranged from $15.59 to $35.87, with a beta of 1.20.
STAAR Surgical Company does not currently pay a dividend.
16 Wall Street analyst ratings cover the stock: 5 Buy, 9 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.